Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74fa5a9700ef5f525e1b6f75b4e30e6b |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-57 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-57 |
filingDate |
2003-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bad8840c38861afd210bec41df3074ea http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44eb598cd86241c30516f2719a728dda |
publicationDate |
2005-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
DE-10355408-A1 |
titleOfInvention |
C1-INH as a drug for the treatment of human-pathogenic viruses |
abstract |
ThenUse of C1-INH for the treatment of viruses is described, thenMembrane components have acceptor punctons, preferably hemagglutininnare. In addition, C1-INH can be used for diagnostic purposes or for cleaningnsuitable viruses are used. |
priorityDate |
2003-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |